Piper Jaffray says the Supreme Court's decision is positive for companies exposed to doctors'...

|By:, SA News Editor

Piper Jaffray says the Supreme Court's decision is positive for companies exposed to doctors' offices, with Genomic Health (GHDX -0.8%) likely the biggest beneficiary. Other names that should benefit include: Gen-Probe (GPRO +0.1%), Hologic (HOLX -1.6%), Qiagen (QGEN -1.8%), EXACT Sciences (EXAS -2.8%) and Meriad Genetics (MYGN +0.2%).